Launch of IF1: A New Anti-Aging Skincare Brand
Overview
Biophysical Therapeutics, based in Wilmington, Delaware, has announced the launch of its consumer longevity brand, IF1, which specializes in anti-aging skincare products. The company is currently accepting pre-orders for its first product, an innovative anti-aging skin moisturizer.
Product Details
- Product: Anti-aging skin moisturizer
- Availability: Pre-orders at www.IF1.skin
- Initial Production: Limited to 500 units
- Price: $120 each
Unique Selling Proposition
The moisturizer incorporates cutting-edge longevity science, with profits aimed at funding research and development for treatments against cancer and age-related diseases, including Alzheimer’s disease. The foundation of their product rests on the science behind IF1 protein, which has been linked to increased lifespans in various mammals.
Company Background
- Founded: In 2022 by Dr. Michael Forrest, a biochemistry graduate from Cambridge University with a Ph.D. in computer science.
- Advisory Support: Professor George Church from Harvard Medical School.
- Specialty: Focuses on computational biology and biophysical modeling, with a track record of developing new experimental drugs.
Market Insights
The anti-aging skincare market is valued at $70 billion and shows significant growth potential, projected to yield substantial economic benefits through increased life expectancy.
Statement from Leadership
Dr. Forrest emphasized the mission of IF1:
“Our IF1 brand brings leading-edge anti-aging science to skincare. This is just part of our mission to save, improve, and extend lives at mass scale.”
Conclusion
The IF1 anti-aging skin moisturizer represents a fusion of science and skincare innovation, and is indicative of a growing trend in the health and longevity sector. Pre-orders are currently being accepted at www.IF1.skin.
For more detailed information, check the full story at PRZen.
